WEE1 and cancer: WEE1 inhibitors can promote cell death of genomically unstable cancers as individual agents, and also have the potential to synergize with radiotherapy and other DNA-damaging chemotherapies by limiting S/G2/M phase checkpoint repair, enhancing chromosomal damage and mitotic catastrophe [26].